SAN DIEGO, Feb. 24 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. today announced the pricing of a public offering of 4,250,000 shares of its common stock. The offering is expected to close on or about March 1, 2010, subject to customary closing conditions. In addition, Optimer has granted the underwriter a 30-day option to purchase up to an additional 637,500 shares to cover over-allotments, if any.
Jefferies & Company, Inc. is acting as sole book-running manager in this offering.
Forward-Looking Statements
Photo: http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.comOptimer Pharmaceuticals, Inc.
